Kristen Smith Grannis

Nexus Systems has announced its sale to Bottomline Technologies. Terms were not disclosed. Nexus Systems, a leading provider of accounts payable and payments automation software for the real estate and property management industries, was a portfolio company of Mainsail Partners, a leading technology investor. Latham & Watkins LLP represents Nexus Systems in the transaction with a corporate deal team led by Boston partners Kristen Grannis, John Miller, and Ryan McCarthy, with associates Laki Triantafylidis and Dante Spurlock. Advice has also been provided on tax matters by New York partner Matthew Dewitz and associate Shruti Hazra; on employee benefits matters by New York partner Jennifer Pepin and associate Madeline Hong; on finance matters by Bay Area partners Haim Zaltzman and Dan Van Fleet, with associate Trevor Church; on intellectual property and data privacy matters by Boston partner Sarah Gagan and associate Deborah Hinck; and on regulatory matters by Washington, D.C. partner Ian Conner and counsel Peter Todaro.~~

Sep 15

1 min

Global alternative asset management firm TPG will acquire a majority stake in critical infrastructure provider Sabre Industries Inc. from Blackstone Energy Transition Partners in a deal guided by Latham & Watkins LLP, Kirkland & Ellis LLP, and Vinson & Elkins LLP, the companies announced Friday. According to the announcement, TPG used its TPG Rise Climate investment platform to obtain the majority stake, and the deal is supposed to be completed in the second quarter of 2026. Blackstone will keep its minority stake in Sabre, which initially received investments from Blackstone's managed funds in 2021, the companies said. According to the announcement, Sabre has 2,800 employees, and its clients include data centers and telecommunications companies. In a Friday article about the deal, Reuters reported that Sabre is worth $3.5 billion. In separate Friday statements, executives for all three companies praised the deal, with TPG partner Steven Mandel describing the transaction as "a significant opportunity." "We believe there is a significant opportunity for leading equipment providers to meet rising electricity demand and modernize a grid increasingly vulnerable to extreme weather events," Mandel said. "Sabre's leadership in transmission and distribution, combined with its specialized enclosures for the data center market, positions the company at the heart of these essential trends." TPG declined to provide additional comment Friday. Blackstone and Sabre didn't respond to requests for additional comment. TPG is represented by Kristen Grannis, James Garrett, John Miller, Jameson Miller, Kevin Donovan, David Lee, Talia Wyschogrod, Jennifer Boyd, Harrison Little, Alec Born, James Langlois, Katharine Moir, Greg Conyers, Ben Rosemergy, Victoria Wolfe, Alyssa Dantoin, Sandy Benjamin, Sahar Merchant, Elizabeth Gemdjian, Debbie Hinck, Susana Santos, Victoria Allen, Scott Joiner, C.J. Rydberg, Julia Hatcher, Josh Marnitz, Anna Dykema, Phil Goldberg, Harrison White, Amara Banks, Enrique Covarrubias, Shira Bressler, and Brandon Hemans of Latham & Watkins LLP and Scott Rolnik, Lauren Nickoloff, Shelby Lindholm, Emily Barber, Michael Urschel, Brandon Karas, and Jared Rusman of Kirkland & Ellis LLP. Blackstone is represented by Benji Barron, Jordan M. Fossee, Zac Horne, Rylie Goldwait, Chet Wynne, Domonique Richardson, Jason McIntosh, Brian Russell, Patrick Darby, David Wicklund, Megan Hardy, Dane Rogerson, Hill Wellford, Kara Kuritz, Ryan Will, Matt Dobbins, Kelly Rondinelli, Becky Baker, Peter Goetschel, Shane Tucker, Kenneth Strain, Madeline O'Neill, Sarah Mitchell, Victoria Bahrami-Negad, Jamie Leader, Courtney Hammond, Rajesh Patel, Haley Titcomb, Fry Wernick, Brian Howard, Joyce Adetutu, Randall Johnston, Frankie Vélez, and Claire Connor of Vinson & Elkins LLP.

Feb 6

2 min

Enko, the crop health company, has announced a US$70 million Series C funding round, bringing the company's overall capital raised to date to US$140 million. Global agrochemical company Nufarm led the round as part of an expanded partnership to bring innovative products to their core markets. Latham & Watkins LLP represents Enko in the financing with a Boston-based corporate team led by partners Kristen Grannis and Spencer Ricks, with associate Andrew Rondeau.~~

Jul 28

1 min

Invetx, Inc., a pioneer in protein-based therapeutics for animal health, has announced that it has agreed to be acquired by Dechra Pharmaceuticals Limited (Dechra), an international veterinary pharmaceuticals business, for up to US$520 million in total consideration on a cash-free and debt-free basis. The acquisition remains subject to antitrust approval and other customary closing conditions. Latham & Watkins LLP represents Invetx in the transaction with a corporate deal team led by Boston/New York partner Kristen Grannis, Boston partner Spencer Ricks, and Boston counsel Gloria Ring, with associates Andrew Rondeau and Christine Kalpin. Advice was also provided on benefits and compensation matters by Boston partner Josh Friedman, with associate Tessa Young; on tax matters by Bay Area partner Grace Lee, with associate Dennis Poehland; on antitrust matters by Bay Area partner Josh Holian and Washington, D.C. partners Ian Conner and Patrick English, with associate Ehson Kashfipour; on intellectual property matters by Boston partner Sarah Gagan and New York counsel Eliot Choy, with associate Arun Mohan; on data privacy matters by Bay Area partner Heather Deixler, with associate Mitch Bennett; on FDA regulatory matters by Washington, D.C. partner Elizabeth Richards, with associate Meryl Bartlett; and on EU regulatory matters by Brussels/Paris partner Eveline Van Keymeulen, with associate Jeanne Fabre.~~

Jul 19

1 min

Invetx, a pioneer in protein-based therapeutics for animal health, has announced that it has raised US$60.5 million in an oversubscribed Series B financing. The investment was led by F-Prime Capital, Novo Holdings, GV (formerly Google Ventures) and Eight Roads, with participation from existing investors Anterra Capital, Casdin Capital and funds managed by Tekla Capital Management, LLC. The proceeds allow the company to advance its monoclonal antibody (mAb) pipeline and pursue market approvals for therapeutics targeting chronic and serious diseases in dogs and cats. Latham & Watkins advised Invetx on its financing round with a corporate deal team led by Boston partners Spencer Ricks and Kristen Grannis, with associates Peter Prial and Andrew Rondeau.~~

May 10

1 min